Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the usual study details, with a minimal header and a Home button. This indicates restricted access to the record rather than an update to the study information.SummaryDifference21%

- Check62 days agoChange DetectedNew study-contact and site entries were added: Sarah Richman, MD and Arthur M Blank Hospital - Children's Healthcare of Atlanta on 2026-09-02 and 2026-08-31. An earlier entry for Neena Kapoor, MD at Arthur M. Blank Hospital (Pediatrics) was removed on 2026-07-31 and 2026-07-29.SummaryDifference0.2%

- Check69 days agoChange DetectedThe page's revision tag updates from v3.6.5 to v3.6.6, indicating a minor version update in the site's metadata. This change does not affect the study details or user-visible content.SummaryDifference0.0%

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.